← Back to Clinical Trials
Recruiting Phase 1 NCT05147675
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA
Trial Parameters
Condition Osteoarthritis
Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 92
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2022-12-01
Completion 2027-12-01
All Conditions
Interventions
AlloRx
Brief Summary
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously and intraarticularly for the treatment of Osteoarthritis.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Osteoarthritis * Understanding and willingness to sign a written informed consent document Exclusion Criteria: * Active infection * Active cancer * Chronic multisystem organ failure * Pregnancy * Clinically significant Abnormalities on pre-treatment laboratory evaluation * Medical condition that would (based on the opinion of the investigator) compromise patient's safety. * Continued drug abuse * Pre-menopausal women not using contraception * Previous organ transplant * Hypersensitivity to sulfur
Related Trials
NCT06825650
Investigation of the Cultural Adaptation, Validity, and Reliability of the Turkish Version of the CA
View Trial →
NCT06148779
Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care
View Trial →
NCT06167928
Developing Allogeneic Musculoskeletal Therapies
View Trial →